[go: up one dir, main page]

AU2002233220A1 - Medicament for preventing or treating tumors caused by human papilloma virus type 18 - Google Patents

Medicament for preventing or treating tumors caused by human papilloma virus type 18

Info

Publication number
AU2002233220A1
AU2002233220A1 AU2002233220A AU3322002A AU2002233220A1 AU 2002233220 A1 AU2002233220 A1 AU 2002233220A1 AU 2002233220 A AU2002233220 A AU 2002233220A AU 3322002 A AU3322002 A AU 3322002A AU 2002233220 A1 AU2002233220 A1 AU 2002233220A1
Authority
AU
Australia
Prior art keywords
medicament
preventing
virus type
papilloma virus
human papilloma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002233220A
Inventor
Josef Gabelsberger
Ruth Herbst
Rainer Muller
John Nieland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medigene AG
Original Assignee
Medigene AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medigene AG filed Critical Medigene AG
Publication of AU2002233220A1 publication Critical patent/AU2002233220A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002233220A 2000-12-01 2001-11-30 Medicament for preventing or treating tumors caused by human papilloma virus type 18 Abandoned AU2002233220A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10059630.4 2000-12-01
DE2000159630 DE10059630A1 (en) 2000-12-01 2000-12-01 Medicines to prevent or treat tumor caused by human papillomavirus type 18
PCT/EP2001/014038 WO2002043757A2 (en) 2000-12-01 2001-11-30 Medicament for preventing or treating tumors caused by human papilloma virus type 18

Publications (1)

Publication Number Publication Date
AU2002233220A1 true AU2002233220A1 (en) 2002-06-11

Family

ID=7665349

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002233220A Abandoned AU2002233220A1 (en) 2000-12-01 2001-11-30 Medicament for preventing or treating tumors caused by human papilloma virus type 18

Country Status (4)

Country Link
US (1) US20040101533A1 (en)
AU (1) AU2002233220A1 (en)
DE (1) DE10059630A1 (en)
WO (1) WO2002043757A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4474264B2 (en) 2004-08-20 2010-06-02 生寶生物科技股▲ふん▼有限公司 Fusion protein of cervical cancer suppression
US7354719B2 (en) 2004-12-08 2008-04-08 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
BRPI0811016B1 (en) 2007-04-29 2021-09-21 Xiamen Innovax Biotech Co., Ltd. LI TRUNCATE PROTEIN FROM HUMAN PAPILOMA VIRUS TYPE 16
BRPI0815818A2 (en) * 2007-04-29 2016-08-02 Beijing Wantai Biological Pharmacy Entpr Co Ltd human papilloma virus type 18 truncated l1 protein
US20130171128A1 (en) * 2010-03-02 2013-07-04 Amgen Inc. Reducing viscosity of pharmaceutical formulations
JP2013521000A (en) * 2010-03-04 2013-06-10 パーデュー・リサーチ・ファウンデーション Integrated test method combining flow cytometry and multiple HPV genotyping
US9737250B2 (en) * 2013-03-15 2017-08-22 Dexcom, Inc. Membrane for continuous analyte sensors
KR101680567B1 (en) 2014-07-09 2016-11-29 연세대학교 산학협력단 Use of HPV peptide for diagnostic and treatment of cervical cancer
WO2016006873A1 (en) * 2014-07-09 2016-01-14 연세대학교 산학협력단 Use of human papillomavirus peptide for diagnosis and treatment of cervical cancer
WO2021013063A1 (en) * 2019-07-19 2021-01-28 神州细胞工程有限公司 Chimeric human papillomavirus type 16 l1 protein
US20230087422A1 (en) * 2020-02-07 2023-03-23 Isa Pharmaceuticals B.V. Treatment of hpv-related diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004687A (en) * 1985-05-21 1991-04-02 University Of Georgia Research Foundation, Inc. Insect virus vector with broadened host range
US5820870A (en) * 1995-03-22 1998-10-13 Merck & Co., Inc. Recombinant human papillomavirus type 18 vaccine
US6228368B1 (en) * 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use
DE19812941A1 (en) * 1998-03-24 1999-10-07 Medigene Ag Medicines to prevent or treat papilloma virus-specific tumor

Also Published As

Publication number Publication date
DE10059630A1 (en) 2002-06-06
WO2002043757A2 (en) 2002-06-06
US20040101533A1 (en) 2004-05-27
WO2002043757A3 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
AU2001227837A1 (en) Novel treatment for eye disease
AU2001233299A1 (en) Methods for treating alzheimer's disease
HUP0301308A3 (en) Human papilloma virus treatment
IL158107A0 (en) Human papillomaviruses vaccine
IL146119A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
AU2317699A (en) Dental restoratives
AU2001284413A1 (en) Medicinal compositions for preventing or treating heart failure
AU2001275848A1 (en) Fabric treatment composition
AU5215300A (en) Dental treatment area
AU2000265525A1 (en) Medicament for treating intestinal diseases
EP1440691A3 (en) Treatment of neurotic disorders
AU2002233220A1 (en) Medicament for preventing or treating tumors caused by human papilloma virus type 18
AU2001274877A1 (en) Pest treatment composition
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU2021601A (en) Composition for the treatment of dandruff
IL142581A (en) Medicament for treating heart disease
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
ZA200110244B (en) Novel xanthone compounds, their preparation and use as medicament.
ITMI20001848A0 (en) DRUGS FOR INCONTINENCE.
IL140417A0 (en) NOVEL COMPOUNDS DERIVED FROM β-D-XYLOSE, PREPARATION METHOD AND THERAPEUTIC USE
AU1972200A (en) Treatment for fabrics
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2136500A (en) Preparation for dental treatment
AU5416500A (en) Pharmaceutical composition for the treatment of calcification